FDA approves Celltrion's biosimilar to Roche's Herceptin
December 14, 2018 at 17:15 PM EST
The U.S. Food and Drug Administration on Friday approved South Korean drugmaker Celltrion Inc's biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin.